Evidence map›Paper›PMID 25253719›Full record

ArticleMolecular biology of the cell2014

TOR complex 2-Ypk1 signaling regulates actin polarization via reactive oxygen species.

Brad J Niles, Ted Powers

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. mTORC2: a multifaceted regulator of autophagy.Cell communication and signaling : CCS · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Expanding TOR Complex 2 Signaling: Emerging Regulators and New Connections.Frontiers in cell and developmental biology · 2021
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Brad J NilesDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, CA 95616.
Ted PowersDepartment of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, Davis, CA 95616 tpowers@ucdavis.edu.
University of California, Davis · US

Funding

TOR Complex 2 and sphingolipid biosynthesis.R01GM086387 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI POWERS, TED · 2009 to 2012
$1.3M
NIGMS NIH HHS GM086387NIGMS NIH HHS R01 GM086387
6 · The paper itself

Abstract

The evolutionarily conserved mTOR complex 2 (mTORC2) signaling pathway is an important regulator of actin cytoskeletal architecture and, as such, is a candidate target for preventing cancer cell motility and invasion. Remarkably, the precise mechanism(s) by which mTORC2 regulates the actin cytoskeleton have remained elusive. Here we show that in budding yeast, TORC2 and its downstream kinase Ypk1 regulate actin polarization by controlling reactive oxygen species (ROS) accumulation. Specifically, we find that TORC2-Ypk1 regulates actin polarization both by vacuole-related ROS, controlled by the phospholipid flippase kinase Fpk1 and sphingolipids, and by mitochondria-mediated ROS, controlled by the PKA subunit Tpk3. In addition, we find that the protein kinase C (Pkc1)/MAPK cascade, a well-established regulator of actin, acts downstream of Ypk1 to regulate ROS, in part by promoting degradation of the oxidative stress responsive repressor, cyclin C. Furthermore, we show that Ypk1 regulates Pkc1 activity through proper localization of Rom2 at the plasma membrane, which is also dependent on Fpk1 and sphingolipids. Together these findings demonstrate important links between TORC2/Ypk1 signaling, Fpk1, sphingolipids, Pkc1, and ROS as regulators of actin and suggest that ROS may play an important role in mTORC2-dependent dysregulation of the actin cytoskeleton in cancer cells.

Indexed as

Actin CytoskeletonActinsBlotting, WesternCyclin CGlycogen Synthase Kinase 3Mechanistic Target of Rapamycin Complex 2Microscopy, FluorescenceMitogen-Activated Protein KinasesMultiprotein ComplexesMutationPhosphorylationProtein BindingProtein Kinase CProtein KinasesProtein SubunitsReactive Oxygen SpeciesActinsCyclin CFpk1 protein, S cerevisiaeGlycogen Synthase Kinase 3MCK1 protein, S cerevisiaeMechanistic Target of Rapamycin Complex 2Mitogen-Activated Protein KinasesMultiprotein ComplexesPKC1 protein, S cerevisiaeProtein Kinase CProtein KinasesProtein SubunitsReactive Oxygen SpeciesSaccharomyces cerevisiae ProteinsSphingolipidsTOR Serine-Threonine Kinases

Identifiers

PMID25253719
PMCPMC4244204
OpenAlexW1996892859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.